Finch Therapeutics Group
Finch Therapeutics Group is a clinical-stage bio-pharmaceutical company focused on developing and delivering innovative therapies that harness the human gut microbiome. The company was established in 2017 and is headquartered out of Somerville, MA.
Last updated on
About Finch Therapeutics Group
Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$314MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
SomervilleState
MassachusettsCountry
United StatesTech Stack (75)
